/
I ntroduction and background to I ntroduction and background to

I ntroduction and background to - PowerPoint Presentation

christina
christina . @christina
Follow
64 views
Uploaded On 2024-01-29

I ntroduction and background to - PPT Presentation

cerebral vascular disease clinical and preclinical Mechanisms key topics outline by guest speakers Endothelial related mechanisms White matter inflammation and hypoxia   ID: 1042576

discussion mechanisms experimental vascular mechanisms discussion vascular experimental glial groups multicentre participants studies group models translation related endothelial speakers

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "I ntroduction and background to" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Introduction and background to cerebral vascular disease(clinical and pre-clinical)Mechanisms (key topics)(outline by guest speakers)Endothelial related mechanisms White matter, inflammation and hypoxia Modelling the NVU in vitroExtracellular matrix proteins  Perivascular drainage pathways  Neuro-glial-vascular mechanismsThemed Discussion Groups (10-12 participants/group)Experimental models Blood brain barrier and endothelial related dysfunctionHypoperfusion/ischaemiaWhite matterDrainage pathwaysInflammatory mechanisms /interactions with systemic circulationNeuro- glial - vascular mechanisms Feedback from each discussion groupGaps and opportunities identified Workshop proceedingsImproving translation (key topics) (outline by guest speakers)Experimental design of animal studies Measuring behavioural outcomes  Multicentre preclinical studies Themed Discussion Groups (10-12 participants/group)Improving translation including relevant biomarkers Sharing, model exchange and potential tissue banks Multicentre studies in experimental models of SVD